Cargando…

Inferences for current chronic graft-versus-host-disease free and relapse free survival

This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation. This new summary curve computes the probabilities that a patient is alive in remission and free of severe-to-moderate chronic graft-versus-host disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Solomon, Scott R., Sizemore, Connie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746208/
https://www.ncbi.nlm.nih.gov/pubmed/36513966
http://dx.doi.org/10.1186/s12874-022-01771-x
_version_ 1784849313053016064
author Zhang, Xu
Solomon, Scott R.
Sizemore, Connie
author_facet Zhang, Xu
Solomon, Scott R.
Sizemore, Connie
author_sort Zhang, Xu
collection PubMed
description This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation. This new summary curve computes the probabilities that a patient is alive in remission and free of severe-to-moderate chronic graft-versus-host disease (GVHD) over time. The probability is called Current chronic GVHD-free, Relapse-Free Survival (CGRFS). Based on a multistate model depicting the possible states that a patient may experience after transplant, CGRFS can be formulated as a linear combination of five survival functions. This method is known as the model-free approach. In this paper we provide the inferences of the model-free approach, including estimation of CGRFS, precision evaluation and comparison of CGRFS between two independent samples.
format Online
Article
Text
id pubmed-9746208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97462082022-12-14 Inferences for current chronic graft-versus-host-disease free and relapse free survival Zhang, Xu Solomon, Scott R. Sizemore, Connie BMC Med Res Methodol Research This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation. This new summary curve computes the probabilities that a patient is alive in remission and free of severe-to-moderate chronic graft-versus-host disease (GVHD) over time. The probability is called Current chronic GVHD-free, Relapse-Free Survival (CGRFS). Based on a multistate model depicting the possible states that a patient may experience after transplant, CGRFS can be formulated as a linear combination of five survival functions. This method is known as the model-free approach. In this paper we provide the inferences of the model-free approach, including estimation of CGRFS, precision evaluation and comparison of CGRFS between two independent samples. BioMed Central 2022-12-13 /pmc/articles/PMC9746208/ /pubmed/36513966 http://dx.doi.org/10.1186/s12874-022-01771-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Xu
Solomon, Scott R.
Sizemore, Connie
Inferences for current chronic graft-versus-host-disease free and relapse free survival
title Inferences for current chronic graft-versus-host-disease free and relapse free survival
title_full Inferences for current chronic graft-versus-host-disease free and relapse free survival
title_fullStr Inferences for current chronic graft-versus-host-disease free and relapse free survival
title_full_unstemmed Inferences for current chronic graft-versus-host-disease free and relapse free survival
title_short Inferences for current chronic graft-versus-host-disease free and relapse free survival
title_sort inferences for current chronic graft-versus-host-disease free and relapse free survival
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746208/
https://www.ncbi.nlm.nih.gov/pubmed/36513966
http://dx.doi.org/10.1186/s12874-022-01771-x
work_keys_str_mv AT zhangxu inferencesforcurrentchronicgraftversushostdiseasefreeandrelapsefreesurvival
AT solomonscottr inferencesforcurrentchronicgraftversushostdiseasefreeandrelapsefreesurvival
AT sizemoreconnie inferencesforcurrentchronicgraftversushostdiseasefreeandrelapsefreesurvival